This paper is in the following e-collection/theme issue:

Protocols for Public Health Research and Surveillance (107) HIV/AIDS/STI Prevention and Care (1043) LGBTQ Issues (543) Prevention and Health Promotion (1362) mHealth in the Developing World/LMICs, Underserved Communities, and for Global Health (717) Online Dating, Sexual Health Behavior (191)

Published on in Vol 9 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/44961, first published .
Long-Acting Injectable Cabotegravir for HIV Preexposure Prophylaxis Among Sexual and Gender Minorities: Protocol for an Implementation Study

Long-Acting Injectable Cabotegravir for HIV Preexposure Prophylaxis Among Sexual and Gender Minorities: Protocol for an Implementation Study

Long-Acting Injectable Cabotegravir for HIV Preexposure Prophylaxis Among Sexual and Gender Minorities: Protocol for an Implementation Study

Authors of this article:

Beatriz Grinsztejn1 Author Orcid Image ;   Thiago Silva Torres1 Author Orcid Image ;   Brenda Hoagland1 Author Orcid Image ;   Emilia Moreira Jalil1 Author Orcid Image ;   Ronaldo Ismerio Moreira1 Author Orcid Image ;   Gabrielle O'Malley2 Author Orcid Image ;   Starley B Shade3 Author Orcid Image ;   Marcos R Benedetti1 Author Orcid Image ;   Julio Moreira4 Author Orcid Image ;   Keila Simpson5 Author Orcid Image ;   Maria Cristina Pimenta6 Author Orcid Image ;   Valdiléa Gonçalves Veloso1 Author Orcid Image ;   The ImPrEP CAB-Brasil Study Team7
Article Authors Cited by (6) Tweetations (2) Metrics

Journals

  1. Torres T, Teixeira S, Hoagland B, Konda K, Derrico M, Moreira R, Guanira J, Benedetti M, Nazer S, Calvo G, Vargas S, Benites C, Bigolin Á, Alonso Neto J, Farias A, Guimarães Lacerda M, Raenck Silva D, Paz L, Madruga J, Salvatierra Flores H, Boluarte G, Osco Tamayo C, Castro Antezana H, Pimenta M, Bórquez A, Luz P, Grinsztejn B, Szwarcwald C, Cáceres C, Veloso V, Kristic T, Rocha C, da Silva Santos W, Lovreto Santana A, Lima R, Souza C, Oliva T, Valões M, Olivetto J, Mota G, Cano A, Trefiglio R, Coutinho C, Elorreaga O, Gutierrez X, Olivos F, Caviedes D, Adriazola D, Juárez E, Mariño G, Qquellon J, Vasquez F, Jiron J, Flores S, Campos K, Eguiluz M. Recent HIV infection and annualized HIV incidence rates among sexual and gender minorities in Brazil and Peru (ImPrEP seroincidence study): a cross-sectional, multicenter study. The Lancet Regional Health - Americas 2023;28:100642 View
  2. Braz Junior R, Cesar G, Amianti C, Bandeira L, Da Silva A, Motta-Castro A. Behind Prep Decisions: Understanding User Patterns and Discontinuation Factors in Real-World. AIDS and Behavior 2024;28(9):2979 View
  3. Pimenta M, Torres T, Hoagland B, Cohen M, Mann C, Jalil C, Carvalheira E, Freitas L, Fernandes N, Castanheira D, Benedetti M, Moreira J, Simpson K, Trefiglio R, O’Malley G, Veloso V, Grinsztejn B. Preparing for the Implementation of Long-Acting Injectable Cabotegravir for HIV Pre-Exposure Prophylaxis Within the Brazilian Public Health System (ImPrEP CAB Brasil): Qualitative Study. JMIR Public Health and Surveillance 2024;10:e60961 View
  4. Pimenta C, Mann C, Hoagland B, Carvalheira E, Jalil C, Benedetti M, Fernandes N, Coutinho C, Jalil E, Secco Torres Silva M, Trefiglio R, Farias A, Mourão M, Madruga J, de Lima J, Zonta R, O'Malley G, Veloso V, Grinsztejn B, Torres T. Exploring perceptions and preferences for PrEP choice and of an mHealth intervention: insights from the ImPrEP CAB‐Brasil study. Journal of the International AIDS Society 2025;28(S2) View
  5. Parikh U, Jacobs J, Njuguna N, Torjesen K, Mellors J. HIV‐1 testing in the context of expanding PrEP modalities. Journal of the International AIDS Society 2025;28(S2) View
  6. Magno L, Leite B, Grangeiro A, Dezanet L, Soares F, Dourado I. Awareness and intention to use event‐driven and long‐acting injectable pre‐exposure prophylaxis among adolescent and young men who have sex with men and transgender women in Brazil: a cross‐sectional study. Journal of the International AIDS Society 2025;28(S2) View